오클라호마의 비소세포폐암 임상 시험
비소세포폐암 관련 연구 35개가 오클라호마 내 여러 지역에서 참여자를 모집하고 있습니다.
오클라호마의 도시
공식 연구 텍스트(영어)
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Mercy Coletta Cancer Center, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07488676Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06498635BostonGene and Exigent Genomic INsight Study
- Oklahoma Cancer Specialists and Research Institute, Tulsa
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06272864Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Cancer Centers of Southwest Oklahoma Research, Lawton
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
- 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04267848A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Hightower Clinical, LLC ( Site 0084), Oklahoma City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06312137Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07388524Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of Oklahoma - Health Sciences Center, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Mercy Hospital Oklahoma City, Oklahoma City
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
- OU Health Stephenson Cancer Center, Oklahoma City
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07857616Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT03191149FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Stephenson Cancer Center, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06303505A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- OU Health Stephenson Cancer Center, Oklahoma City
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06720987Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
- INTEGRIS Cancer Institute of Oklahoma, Oklahoma City
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06712316Study of XB010 in Subjects With Solid Tumors
- Stephenson Cancer Center, Oklahoma City
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06545331Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
- OU Health Stephenson Cancer Center, Oklahoma City
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07807345A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
- Local Institution - 0418, Oklahoma City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07361510KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- OU Stephenson Cancer Center, Oklahoma City
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT06026410Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
- Cancer Centers of Southwest Oklahoma Research, Lawton
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06116682Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Cancer Centers of Southwest Oklahoma Research, Lawton
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중2상
18 Minutes · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Cancer Centers of Southwest Oklahoma Research, Lawton
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06616584The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Oklahoma, Oklahoma City
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750Pan-tumor MRD Study
- Oklahoma Cancer Specialists and Research Institute (OCSRI), Tulsa
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06605404Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Oklahoma, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
- Clinical Study Site, Oklahoma City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06767514A Phase 1/1b Study of IAM1363 in HER2 Cancers
- OU Health Stephenson Cancer Center, Oklahoma City
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06500481Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 14. 업데이트됨 · NCT06686771A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- OU Health University of Oklahoma Medical Center, Oklahoma City
- Stephenson Cancer Center (chemo location), Oklahoma City
- University of Oklahoma Health Science Center, Oklahoma City
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT04389632Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - OKC, Oklahoma City
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT07327489Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Cancer Centers of Southwest Oklahoma Research, Lawton
- University of Oklahoma Health Sciences Center, Oklahoma City
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05642572Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
- Sarah Cannon Research Institute University of Oklahoma, Oklahoma City
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 5. 19. 업데이트됨 · NCT05431270GEMINI-NSCLC: NSCLC Biomarker Study
- Hightower Clinical, Oklahoma City
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
- Oklahoma Cancer Specialists and Research Institute, Tulsa
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 2. 5. 업데이트됨 · NCT05236114A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Oklahoma City
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 1. 7. 업데이트됨 · NCT06999187SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774A Study of NX-1607 in Adults With Advanced Malignancies
- University of Oklahoma, Oklahoma City
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 9. 9. 업데이트됨 · NCT05107674ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.